Drug intelligence / Profile preview

Jinseng Tsai Tsao Wan

Development stage: Unknown
Lead developer: Beijing Tong Ren Tang
Administration: Oral

Overview

Jinseng Tsai Tsao Wan (also known as Renshen Zaizao Wan or Ginseng Restorative Pill) is a traditional Chinese medicine (TCM) proprietary formulation developed and manufactured by Beijing Tong Ren Tang. It is composed of dozens of natural ingredients, including ginseng, processed snake, notoginseng, and other botanical and animal-derived substances. The formulation is traditionally used to replenish qi, nourish blood, dispel wind, resolve phlegm, and promote blood circulation to remove meridian obstruction. It is primarily indicated for the treatment and recovery of stroke (apoplexy) and its sequelae, including symptoms such as facial paralysis, hemiplegia, limb numbness, muscle spasms, and slurred speech.

Brand names: Jinseng Tsai Tsao Wan
Other names: Ginseng Restorative PillGinseng Zaizao WanRenshen Zaizao Wan人参再造丸

Beyond the preview

Go deeper on Jinseng Tsai Tsao Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinseng Tsai Tsao Wan.